Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis
- PMID: 18793553
- DOI: 10.5414/cnp70069
Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis
Abstract
Glomerulonephritis (GN) is an uncommon but well-described complication of chronic hepatitis B virus (HBV) infection. HBV-related membranous nephropathy (MN) may lead to renal failure in 1/3 of the patients and spontaneous remission is rare. There is no standard therapy for HBV-associated MN. We report a case of a 28-year-old man with HBV-associated MN due to pre-core HBV mutant with complete remission under an ongoing 7-year lamivudine monotherapy.